Literature DB >> 35790663

A pH/Time/Pectinase-Dependent Oral Colon-Targeted System Containing Isoliquiritigenin: Pharmacokinetics and Colon Targeting Evaluation in Mice.

XiaoFei Tang1, XiaoYun Zhang2, QianQian Zhao1.   

Abstract

BACKGROUND AND OBJECTIVES: Oral colon-targeted gel beads containing isoliquiritigenin (ISL) were successfully designed in our study. In order to further explore the targeting of the colon by the gel beads, a systematic study of their in vivo pharmacokinetics and colon targeting was performed in mice.
METHODS: Eighteen male mice were included in this study. The mice were separated into six groups at random. We collected blood, stomach, duodenum, jejunum, ileum, and colon tissues at 2, 4, 6, 8, 12, and 24 h after oral administration of gel beads containing isoliquiritigenin at a dose of 20 mg/kg. Gel beads in tissues were recorded and taken out to observe their swelling and erosion. The total ISL concentrations in different tissues and gel beads were analyzed by high-performance liquid chromatography.
RESULTS: All gel beads reached the upper part of the stomach at 2 h with no obvious swelling. Most of the gel beads were still in the lower part of stomach, while a small amount had reached the small intestine at 4 h. A few gel beads reached the colon and swelled at 6 h. Furthermore, the gel beads in the colon were swollen and erosive at 8 h. Meanwhile, the plasma ISL concentration could be detected, which indicated that the ISL in the gel beads was absorbed. At 12 h, the gel beads were almost dissolved and the plasma concentration was 8.33 times that at 8 h. At 24 h, the gel beads had completely disappeared, and the plasma concentration was 2.55 times that at 12 h.
CONCLUSION: The gel beads containing ISL are a sustained, controlled, and colon-targeting delivery system that can alter the ISL distribution in the gastrointestinal tract.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35790663     DOI: 10.1007/s13318-022-00783-8

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.569


  11 in total

1.  Colon targeted drug delivery systems: a review on primary and novel approaches.

Authors:  Anil K Philip; Betty Philip
Journal:  Oman Med J       Date:  2010-04

2.  Isoliquiritigenin protects against sepsis-induced lung and liver injury by reducing inflammatory responses.

Authors:  Xiong Chen; Xueding Cai; Rongrong Le; Man Zhang; Xuemei Gu; Feixia Shen; Guangliang Hong; Zimiao Chen
Journal:  Biochem Biophys Res Commun       Date:  2017-11-24       Impact factor: 3.575

3.  A colon targeted drug delivery system based on alginate modificated graphene oxide for colorectal liver metastasis.

Authors:  Bin Zhang; Yayuan Yan; Qiujuan Shen; Dong Ma; Langhuan Huang; Xiang Cai; Shaozao Tan
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2017-05-10       Impact factor: 7.328

Review 4.  Site-specific drug delivery systems within the gastro-intestinal tract: from the mouth to the colon.

Authors:  João F Pinto
Journal:  Int J Pharm       Date:  2010-05-28       Impact factor: 5.875

5.  Preparation of isoliquiritigenin-loaded nanostructured lipid carrier and the in vivo evaluation in tumor-bearing mice.

Authors:  Xiao Yun Zhang; Hua Qiao; Jing Man Ni; Yan Bin Shi; Yin Qiang
Journal:  Eur J Pharm Sci       Date:  2013-04-25       Impact factor: 4.384

6.  Effects of isoliquiritigenin on ovarian antral follicle growth and steroidogenesis.

Authors:  Sharada Mahalingam; Liying Gao; Jacqueline Eisner; William Helferich; Jodi A Flaws
Journal:  Reprod Toxicol       Date:  2016-10-20       Impact factor: 3.143

7.  Isoliquiritigenin suppresses the proliferation and induced apoptosis via miR-32/LATS2/Wnt in nasopharyngeal carcinoma.

Authors:  Ting-Ting Wang; Zhen-Zhang Chen; Peng Xie; Wen-Jun Zhang; Ming-Yu Du; Ya-Tian Liu; Hua-Yun Zhu; Ye-Song Guo
Journal:  Eur J Pharmacol       Date:  2019-04-17       Impact factor: 4.432

8.  Hierarchically targetable polysaccharide-coated solid lipid nanoparticles as an oral chemo/thermotherapy delivery system for local treatment of colon cancer.

Authors:  Ming-Yin Shen; Te-I Liu; Ting-Wei Yu; Reesha Kv; Wen-Hsuan Chiang; Yuan-Chung Tsai; Hsin-Hung Chen; Sung-Chyr Lin; Hsin-Cheng Chiu
Journal:  Biomaterials       Date:  2019-01-09       Impact factor: 12.479

9.  Pharmacokinetics, biodistribution and bioavailability of isoliquiritigenin after intravenous and oral administration.

Authors:  Hua Qiao; Xiaoyun Zhang; Ting Wang; Li Liang; Wei Chang; Huxiong Xia
Journal:  Pharm Biol       Date:  2013-10-09       Impact factor: 3.503

10.  Characterization, release, and antioxidant activity of curcumin-loaded sodium alginate/ZnO hydrogel beads.

Authors:  Heping Wang; Xuechen Gong; Xia Guo; Chun Liu; Yan-Ying Fan; Jin Zhang; Baolong Niu; Wenfeng Li
Journal:  Int J Biol Macromol       Date:  2018-10-16       Impact factor: 6.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.